Rhenman & Partners Asset Management AB as of Sept. 30, 2015
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 91 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amgen (AMGN) | 3.0 | $19M | 135k | 138.32 | |
| Alexion Pharmaceuticals | 2.9 | $18M | 115k | 156.39 | |
| Medtronic (MDT) | 2.8 | $18M | 265k | 66.94 | |
| UnitedHealth (UNH) | 2.7 | $17M | 147k | 116.01 | |
| Eli Lilly & Co. (LLY) | 2.5 | $16M | 185k | 83.69 | |
| Aetna | 2.4 | $15M | 138k | 109.41 | |
| Alkermes (ALKS) | 2.4 | $15M | 255k | 58.67 | |
| Anthem (ELV) | 2.4 | $15M | 107k | 140.00 | |
| Celgene Corporation | 2.4 | $15M | 136k | 108.17 | |
| CIGNA Corporation | 2.3 | $14M | 106k | 135.02 | |
| Humana (HUM) | 2.3 | $14M | 80k | 179.00 | |
| McKesson Corporation (MCK) | 2.3 | $14M | 77k | 185.03 | |
| Hca Holdings (HCA) | 2.2 | $14M | 180k | 77.36 | |
| Pfizer (PFE) | 2.1 | $13M | 421k | 31.41 | |
| Allergan | 2.0 | $13M | 46k | 271.80 | |
| Cardinal Health (CAH) | 1.9 | $12M | 159k | 76.82 | |
| Incyte Corporation (INCY) | 1.9 | $12M | 109k | 110.33 | |
| Becton, Dickinson and (BDX) | 1.9 | $12M | 91k | 132.66 | |
| St. Jude Medical | 1.9 | $12M | 190k | 63.09 | |
| Abbvie (ABBV) | 1.8 | $11M | 210k | 54.41 | |
| Bristol Myers Squibb (BMY) | 1.8 | $11M | 192k | 59.20 | |
| Gilead Sciences (GILD) | 1.8 | $11M | 115k | 98.19 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.7 | $11M | 105k | 104.14 | |
| Perrigo Company (PRGO) | 1.6 | $10M | 65k | 157.28 | |
| Centene Corporation (CNC) | 1.5 | $9.5M | 175k | 54.23 | |
| Community Health Systems (CYH) | 1.5 | $9.4M | 220k | 42.77 | |
| CVS Caremark Corporation (CVS) | 1.5 | $9.4M | 97k | 96.48 | |
| BioMarin Pharmaceutical (BMRN) | 1.4 | $9.1M | 86k | 105.33 | |
| Health Net | 1.4 | $9.0M | 150k | 60.22 | |
| Edwards Lifesciences (EW) | 1.4 | $8.8M | 62k | 142.18 | |
| Laboratory Corp. of America Holdings | 1.4 | $8.8M | 81k | 108.47 | |
| Cempra | 1.3 | $8.3M | 298k | 27.84 | |
| Express Scripts Holding | 1.2 | $7.8M | 96k | 80.96 | |
| Regeneron Pharmaceuticals (REGN) | 1.2 | $7.7M | 17k | 465.15 | |
| Nektar Therapeutics | 1.2 | $7.5M | 688k | 10.96 | |
| Dex (DXCM) | 1.1 | $7.2M | 84k | 85.86 | |
| Abiomed | 1.1 | $7.0M | 76k | 92.76 | |
| Cerner Corporation | 1.1 | $7.0M | 116k | 59.96 | |
| Zimmer Holdings (ZBH) | 1.1 | $6.6M | 70k | 93.93 | |
| Intra Cellular Therapies (ITCI) | 1.1 | $6.6M | 165k | 40.04 | |
| ACADIA Pharmaceuticals (ACAD) | 1.0 | $6.5M | 196k | 33.07 | |
| Jazz Pharmaceuticals (JAZZ) | 1.0 | $6.2M | 47k | 132.81 | |
| Universal Health Services (UHS) | 1.0 | $6.1M | 49k | 124.81 | |
| Alnylam Pharmaceuticals (ALNY) | 1.0 | $6.1M | 76k | 80.36 | |
| AmerisourceBergen (COR) | 0.9 | $6.0M | 63k | 94.98 | |
| Keryx Biopharmaceuticals | 0.9 | $5.5M | 1.6M | 3.52 | |
| Intercept Pharmaceuticals In | 0.8 | $5.3M | 32k | 165.88 | |
| Endo International | 0.8 | $5.1M | 73k | 69.27 | |
| Zeltiq Aesthetics | 0.8 | $5.0M | 157k | 32.03 | |
| Merck & Co (MRK) | 0.8 | $4.9M | 100k | 49.39 | |
| Supernus Pharmaceuticals (SUPN) | 0.8 | $5.0M | 353k | 14.03 | |
| Cooper Companies | 0.8 | $4.9M | 33k | 148.85 | |
| Medivation | 0.8 | $4.8M | 114k | 42.50 | |
| HeartWare International | 0.7 | $4.6M | 87k | 52.31 | |
| Revance Therapeutics | 0.7 | $4.4M | 148k | 29.76 | |
| Rite Aid Corporation | 0.6 | $4.0M | 665k | 6.07 | |
| Mylan Nv | 0.6 | $4.0M | 100k | 40.26 | |
| Clovis Oncology | 0.6 | $4.0M | 43k | 91.95 | |
| Lion Biotechnologies | 0.6 | $3.9M | 683k | 5.76 | |
| Cyberonics | 0.6 | $3.5M | 57k | 60.77 | |
| ISIS Pharmaceuticals | 0.5 | $3.2M | 80k | 40.42 | |
| Kite Pharma | 0.5 | $3.2M | 57k | 55.68 | |
| Celldex Therapeutics | 0.5 | $3.1M | 295k | 10.54 | |
| Portola Pharmaceuticals | 0.5 | $3.0M | 71k | 42.62 | |
| Insulet Corporation (PODD) | 0.5 | $2.9M | 110k | 25.91 | |
| Endologix | 0.5 | $2.8M | 229k | 12.26 | |
| Orexigen Therapeutics | 0.4 | $2.5M | 1.2M | 2.11 | |
| Ariad Pharmaceuticals | 0.4 | $2.5M | 430k | 5.84 | |
| Catabasis Pharmaceuticals | 0.4 | $2.4M | 300k | 8.09 | |
| Esperion Therapeutics (ESPR) | 0.4 | $2.4M | 100k | 23.59 | |
| Omnicell (OMCL) | 0.4 | $2.3M | 74k | 31.09 | |
| Cepheid | 0.4 | $2.3M | 51k | 45.20 | |
| Halozyme Therapeutics (HALO) | 0.4 | $2.3M | 172k | 13.43 | |
| Macrogenics (MGNX) | 0.4 | $2.3M | 108k | 21.42 | |
| Rigel Pharmaceuticals | 0.4 | $2.3M | 925k | 2.47 | |
| Xencor (XNCR) | 0.3 | $2.2M | 181k | 12.23 | |
| Chimerix (CMRX) | 0.3 | $2.1M | 56k | 38.20 | |
| Lexicon Pharmaceuticals (LXRX) | 0.3 | $2.1M | 200k | 10.74 | |
| Tesaro | 0.3 | $2.0M | 51k | 40.10 | |
| Achillion Pharmaceuticals | 0.3 | $1.9M | 280k | 6.91 | |
| Tandem Diabetes Care | 0.3 | $1.8M | 209k | 8.81 | |
| Array BioPharma | 0.3 | $1.7M | 370k | 4.56 | |
| Tetraphase Pharmaceuticals | 0.3 | $1.7M | 225k | 7.46 | |
| Mirati Therapeutics | 0.3 | $1.7M | 50k | 34.42 | |
| Anthera Pharmaceutcls | 0.2 | $1.5M | 250k | 6.09 | |
| Dynavax Technologies (DVAX) | 0.2 | $1.4M | 55k | 24.55 | |
| Hologic (HOLX) | 0.2 | $1.3M | 33k | 39.13 | |
| Regulus Therapeutics | 0.2 | $1.3M | 200k | 6.54 | |
| Avalanche Biotechnologies In | 0.2 | $1.3M | 154k | 8.24 | |
| Threshold Pharmaceuticals | 0.1 | $820k | 202k | 4.07 | |
| Bind Therapeutics | 0.1 | $596k | 134k | 4.46 |
